Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The Good News and The Bad News, which are sort of the same ...

Otteson said at the shareholder meeting that he felt he could prove infringement with Gildea's claim constructions. These next few days waiting on the Summary motion determination are going to be a little tense. What a wild ride it has been. Please let me off with a smile on my face.

Good Luck

Share
New Message
Please login to post a reply